Spyre Therapeutics, Inc.
Ticker: 1636282
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2023 | Q2 FY2023 | Q2 FY2023 | Q1 FY2023 | Q1 FY2023 | Q1 FY2023 | Q3 FY2022 | Q3 FY2022 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.69+0.0% | 0.69+0.0% | 0.69+245.0% | 0.20+0.0% | 0.20+0.0% | 0.20+17.6% | 0.17+0.0% | 0.17 |
| Total Income | 0.69+0.0% | 0.69+0.0% | 0.69+245.0% | 0.20+0.0% | 0.20+0.0% | 0.20+17.6% | 0.17+0.0% | 0.17 |
| EXPENSES | ||||||||
| Expenditure | 159.93+0.0% | 159.93+0.0% | 159.93+741.7% | 19.00+0.0% | 19.00+0.0% | 19.00+0.4% | 18.93+0.0% | 18.93 |
| Tax | 0.01+0.0% | 0.01+0.0% | 0.01+125.0% | -0.04+0.0% | -0.04+0.0% | -0.04+81.0% | -0.21+0.0% | -0.21 |
| PROFIT | ||||||||
| PBT | -217.07+0.0% | -217.07+0.0% | -217.07-1075.9% | -18.46+0.0% | -18.46+0.0% | -18.46-0.1% | -18.44+0.0% | -18.44 |
| Net Profit | -217.08+0.0% | -217.08+0.0% | -217.08-1078.5% | -18.42+0.0% | -18.42+0.0% | -18.42-1.0% | -18.23+0.0% | -18.23 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -56.79-2401.8% | -2.27-105.7% | 40.14+920.9% | -4.89-2345.0% | -0.20 | — | -4.84-2447.4% | -0.19 |
Corporate Events
Board MeetingSYRE
202627May
Board Meeting
Annual Meeting of Stockholders held; election of Class I dir…
SEC Filing ↗